Immune-cell booster for cancer patients
Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. Researchers from Sai Reddy's group have now developed a technology that avoids these.
An antigen (right) binds to the T-cell (left). Source: ETH Zürich
Contact/Links:
Laboratory for Systems and Synthetic Immunology
More information on the technology
Do you want to get more "News for Industry" stories?
external pageFollow us on LinkedIn
Are you looking for research partners at ETH Zurich?
Contact ETH Industry Relations